Better Survival in BRCA-Mutated Breast Cancer With Neoadjuvant Olaparib-Chemo Combo

By News Health
15 hours Ago

(MedPage Today) — Overall survival (OS) in BRCA-mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to neoadjuvant chemotherapy despite no improvement in pathologic response, a small prospective study showed…

Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/115570

Author :

Publish date : 2025-05-13 20:31:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Early Food Allergy May Increase Odds of Atopic March

Post-Polypectomy Colorectal Cancers Common Before Follow-Up

Adult Sugammadex Dosing Safe, Effective in Kids Aged < 2

Helping on the farm in Surrey is reaping mental health rewards

Three GPs give their views on assisted dying

Sedentary Time Tied to Brain Volume, Worse Cognition in Older Adults